PU files patents for green nanoplatform in skincare and pharma

Chandigarh: Panjab University has filed Indian and international patents for a new green nanomicelle platform developed by Professor Indu Pal Kaur and her PhD scholars Bakr Ahmed and Simrandeep Kaur.

The solvent-free, eco-friendly technology enables targeted delivery of sensitive bioactives such as peptides, herbal extracts, cannabinoids, vitamins, proteins, and small molecules.These components have applications in pharmaceuticals, nutraceuticals, cosmetics, paediatrics, veterinary care, and wellness products.

The platform is scalable and designed for clean-label processes, with formulations developed at room temperature. Minimal use of USFDA-approved solvents is allowed to accommodate poorly soluble actives without compromising safety or scalability. The technology has already been transferred to an industrial partner for skincare and cosmetics applications, marking a key step in academia-industry collaboration.

Professor Indu Pal Kaur, who leads the IPK Lab at Panjab University, described the innovation as affordable and adaptable, supporting both MSMEs and global companies in developing safe and sustainable products. Her lab focuses on turning research challenges into practical solutions, with a strong emphasis on long-term partnerships and technology transfer.
The university’s Centre for Industry-Institute Partnership Programme, established in 1996, plays a vital role in fostering innovation through revenue-sharing models between faculty and the institution.

Panjab University vice-chancellor Renu Vig said the university takes pride in translating research into industry-relevant innovations that improve lives and enhance its academic reputation.
With more than 22 patents granted and 17 filed, Professor Kaur’s work highlights the growing importance of intellectual property in India’s innovation ecosystem.

Related Posts

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Thiruvanantpuram: The Ethics Committee of the Council of Indian Systems of Medicine, Kerala State Medical Councils, has imposed a fine of ₹50,000 on a registered Ayurveda practitioner for advertising his…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

DoP may exempt 11 more drugs from public procurement rules

DoP may exempt 11 more drugs from public procurement rules

DoP calls for proposals to set up common facilities for medical device clusters

DoP calls for proposals to set up common facilities for medical device clusters